#biotech search results
EMVision Medical Devices is progressing its pivotal validation trial across eight major US hospitals as it edges toward a De Novo FDA application for its portable stroke detection device. #ASX #Biotech $EMV buff.ly/WwFIlyF
Pipeline strength and R&D are crucial for #PharmaInvestors, but don't overlook in-licensing! This popular strategy offers significant benefits for pharmaceutical companies. #Licensing #Biotech #LifeScienceInvesting #PharmaceuticalInvesting investingnews.com/daily/life-sci…
LSI's Chuck Offutt is in NYC this week for @INTERPHEX. He is looking forward to engaging in conversations around automation, compliance, validation, and digital solutions that are shaping the future of regulated manufacturing. #INTERPHEX #PharmaManufacturing #Biotech #LSIListens
The biggest breakthroughs in biotech won’t come from isolated labs—but from collaboration across science, technology, and global teams. #Biotech #Collaboration #Healthcare
Define success at the beginning of your project. Make sure everyone's on the same page, because if you don't, you'll wind up in a quagmire at the end. —Patty Aha #HealthyEnterprisePodcast #Biotech #ProjectManagement #Innovation
ACW-ASX is set to skyrocket as latest research reports state the existing FDA approved drugs have little or no meaningful effect in treating Alzheimers Disease. Actinogens Xanamem is set to be the only option to treat the huge unmet need that is Alzheimers #biotech #Alzeihmers
$KTTA granted Rare Pediatric Disease Designation for PAS-004. PRV potential ($150-205M) key catalyst. Stock down >40% YTD. Short-term bounce likely. Risk: clinical binary event. Bullish 1-3 days. Resistance $0.82. Wait above $0.62. #KTTA #Biotech #NASDAQ
Not all marketing tactics bring equal lead quality in healthcare. For complex B2B offerings, the highest-value leads come from: • Thought leadership • Earned media • Educational content • Credibility signals Authority > volume. #HealthIT #Biotech #HealthcareMarketing
$RVPH: Cash Sits At $23 Million, Supporting RECOVER 2 Launch #NeuroInnovation #BioTech #NextGenTherapeutics buff.ly/rra599X
Eli Lilly has agreed to acquire biotech firm Kelonia Therapeutics in a deal worth up to $7 billion, strengthening its push into cancer treatments. #elililly #keloniatherapeutics #biotech #cancerresearch #carttherapy #pharma #healthcare #businessnews #Panamá2026 #Jitokeze
#Switzerland startup Planetary (Enables efficient fermentation-based food ingredient production via a full-stack platform) Raises $27.56M from AgriFoodTech Venture Alliance, Astanor, XAnge #Upcycling #Biotech #Fermentation #FoodTech #Sustainability parsers.vc/startup/planet…
#UnitedStates startup Beeline Medicines (Develops precision therapies for autoimmune and inflammatory diseases) Raises $300M Series A Round from Bain Capital #Biotech #ClinicalStage #Immunology #Pharmaceuticals #Therapeutics parsers.vc/startup/beelin…
Novo Nordisk's etavopivat just aced its Phase 3 trial for sickle cell disease — the first drug in a new class to hit both primary endpoints. A once-daily pill that could transform millions of lives. This is the biotech headline that actually matters. #Biotech #SickleCell
Biotech's biggest breakthroughs lately share a pattern: precision over complexity. They're being solved instead by understanding biology's existing architecture more precisely. #CRISPRTherapy #Biotech
The paper: Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial DOI: 10.1111/jdv.70237 #biotech #hairloss #alopecia #pharma #dermatology #science #biohacker
Watch the Part 5 Teaser to see why the science is stronger than ever. 📊 Full Analysis & Deep-Dives: 🔗 Overview: nucleotec.org/vaxart-oral-va… 🔗 Deep-Dive: nucleotec.org/vaxart-oral-va… @BARDA @ASPRgov #Sentinel400 #Vaxart #Biotech
Take a look inside our biotech factory! See advanced bioreactor production lines built for precision, quality, and reliability. #BiotechFactoryTour #FactoryFloor #BioTech #foryou #fyp
Heading to #BioKorea2026? 🌆 Stop by Booth C11 to meet the @Curi_Bio Korea team! Learn how our 3D engineered human tissues & MOA specification are bridging the gap to clinical reality.🎙️Don't miss our talk Apr 30, Room 317! Book a meeting: hubs.ly/Q04b-Wc80 #NAMs #Biotech
#Switzerland startup KA-EX (Develops a patented formula to improve regeneration and sleep quality, focused on performance and professional sports) Raises $6.01M #Biotech #Health #Nutrition #Supplements #Wellness parsers.vc/startup/ka-ex.…
#1AD $10M MC💥 #Cancer #Biotech NEWS ⏩#1AD,ORIBIOTECH & CELL THERAPIES SIGN MOU⏪ 💥MOU to bring Oribiotech’s automated #celltherapy manufacturing platform, IRO, to Australia & Asia Pacific region 💥IRO aims to address key CAR-T challenges: High cost Slow production
EMVision Medical Devices is progressing its pivotal validation trial across eight major US hospitals as it edges toward a De Novo FDA application for its portable stroke detection device. #ASX #Biotech $EMV buff.ly/WwFIlyF
#1AD $10M MC💥 #Cancer #Biotech NEWS ⏩#1AD,ORIBIOTECH & CELL THERAPIES SIGN MOU⏪ 💥MOU to bring Oribiotech’s automated #celltherapy manufacturing platform, IRO, to Australia & Asia Pacific region 💥IRO aims to address key CAR-T challenges: High cost Slow production
#1AD $10M MC 💥MAJOR CLINICAL UPDATE💥 ⏩Tumour shrinkage, clearance in advanced #mesothelioma patients treated with BZDS1901 support exploration of higher dosing, further clinical development⏪ • All five advanced mesothelioma patients in extension Cohort 1 of the
💥 SURPRISE: $LEGN +18% today. Eli Lilly dropped $7B on a CAR-T play (LLY) and Wall Street immediately repriced every similar name. H.C. Wainwright + RBC both bullish. CAR-T M&A premium is REAL. Who's next on the acquisition list? 👇 #Biotech #CART #MnA
AACR 2026｜YEASEN Booth #4827・Innovative NGS Library Prep Solutions #aacr #Biotech #Sequencing #MolecularBiology #DNAAnalysis #bioscience #biology #NGS
🚀 Wall Street Sees ~41% Upside as Immunology Pivot Unlocks New Growth Engine Read More: tinyurl.com/yk3r49m2 #Biotech #HealthcareInvesting #Equities #Pharma #WallStreet #GrowthStocks #Pipeline #Innovation #Investing
CEO shakeup sinks Fermi. Meanwhile, Lilly gains and Compass Pathways rises. What's moving the needle in biotech today? 🧬 #Biotech #StockMarket
pharmadevicenews.com/akari-therapeu… #Oncology #ADC #Biotech #CancerResearch #ClinicalTrials #TROP2 #DrugDevelopment #PrecisionMedicine #AACR2026
pharmadevicenews.com
Akari Therapeutics Plc advances AKTX-101 as RNA splicing ADC targets TROP2 resistance in oncology -...
Discover how AKTX-101 could redefine TROP2 ADC resistance strategies in oncology. Read the full analysis now.
💥 SURPRISE: $KLRA just raised $718.8M in its IPO — obesity biotech going public at $16/share with ALL 44.9M shares sold including full greenshoe exercise. That's a monster vote of confidence in the GLP-1 space. Bullish or overhyped? 🐺 #IPO #Biotech #KLRA
ACW-ASX is set to skyrocket as latest research reports state the existing FDA approved drugs have little or no meaningful effect in treating Alzheimers Disease. Actinogens Xanamem is set to be the only option to treat the huge unmet need that is Alzheimers #biotech #Alzeihmers
Actinogens Xanamem has no competition in #Alzeihmers space. The drug has a very low bar to jump over for FDA Approval later this year. Read cochrane.org/about-us/news/… for more #$ACW #StockTrading #biotech #Alzeihmerstreatment #bioteschtips #Donenamab #Leqembi #antiamyloiddrugs #ASX
Tune into our first quarter 2026 earnings and business update conference call on Monday, May 4, 2026, at 4:30 p.m. ET. Get the details: bit.ly/4cGIsU3 #biotech #cancer #oncology
Punishing loyal retail investors with a reverse split just to make the price look 'appealing' for big players is not a strategy—it’s a betrayal of loyalty. Let the science drive the price, not accounting maneuvers. We deserve better. $OCGN #Biotech #RetailInvestors
FOX 26 Houston spotlights Diakonos Oncology’s DOC1021, where ~90% of patients showed extended survival in early clinical trials. fox26houston.com/news/experimen… #Biotech #Oncology
Want to put your brand in front of top aging researchers. The American Aging Association Annual Meeting 2026 (Provo, Utah | June 2–5, 2026) is still open for sponsors & exhibitors. Showcase your work. Build partnerships. Contact AGE Central Office. #Aging #Longevity #Biotech
Biotech's biggest breakthroughs lately share a pattern: precision over complexity. They're being solved instead by understanding biology's existing architecture more precisely. #CRISPRTherapy #Biotech
Investors should look at fully diluted shares outstanding #FDSO when looking at the market cap of a company. Dilutive securities, including options, warrants, converts, etc, can have a meaningful impact on the actual market cap of a company #learnbiotechinvesting #biotech
If you're a professional in #ICT, #biotech or #cleantech, Valais is hiring! Join the #WorkinginValais event on 23 April from 10:00 to 12:30 CET to: 💼 Browse open vacancies 🤝 Chat with employers 📝 Learn about working in Valais Register 👉 europeanjobdays.eu/en/event/work-… #EURESJobs
Investors should know WHAT will move a stock and WHEN, especially in biotech with the outsized moves. Build your catalyst calendar ahead of time. You won't have time to thoughtfully analyze the data when it hits #learnbiotechinvesting #biotech #investing #BiotechPrometheus
De kaas die je eet, het medicijn dat je slikt, kansen zijn groot dat er Delftse biotechnologie in zit. Biotech Campus Delft werkt aan duurzamere productie van voeding, medicijnen en materialen. De toekomst wordt hier gemaakt. 🔬👉bit.ly/41JGzRe #Biotech #ZuidHolland
Getting #MoffittBOB started @MoffittNews with an economic development breakfast, welcoming key leaders for a chat about the future of #biotech in our region. Thanks to Tim Plett, Executive Director, Life Sciences and Commercial Banking @jpmorgan for a great presentation.
Teachers, looking for a fun #biotech game for your classroom? In this card game, developed by Ingeborg Van der Neut of ABE The Netherlands, students race to make a finished protein—starting from DNA! amgenbiotechexperience.com/curriculum-res…
Great to have @BioFlorida at @MoffittNews today for a roundtable on strengthening Florida’s #biotech ecosystem and advancing innovation to drive impact for patients. @DrJamesMule @ProfGregSawyer @wjameswilson
💉 Adcendo just raised $75M to supercharge its cancer-fighting ADC pipeline - breakthrough potential ahead! 🧬 Oversubscribed round fuels Phase I trials for ADCE-T02, ADCE-D01 & more against tough tumors Full details link in the comment 👇 #Adcendo #Biotech #CancerTherapy #ADC
Most people in crypto focus on price, but the real edge often comes from understanding on-chain behavior. 🔍 When you track wallet activity, token flows, and smart money movements, you start seeing patterns before they become obvious on the chart. That’s why researchers,
Have you noticed how $XBI hasn’t started Wave II yet? 👀 When Wave I extends like this, the next pullback often catches traders off guard. If you want to read the cycle with precision, check this 👉 elliottwave-forecast.com #Stocks #Biotech #Elliottwave
Have you noticed how $XBI hasn’t started Wave II yet? 👀 When Wave I extends like this, the next pullback often catches traders off guard. If you want to read the cycle with precision, check this 👉 elliottwave-forecast.com #Stocks #Biotech #Elliottwave
Incorporating Probability of Success (PoS) is a unique aspect of #biotech valuation investors must be aware of. It tries to factor development risk into revenue and cost assumptions. Here is a table of PoS values: #learnbiotechinvesting #investing #BiotechPrometheus
Grateful to @FLSecofCommerce Alex Kelly for his leadership in advancing #biotech growth and innovation in Florida. Thank you for joining us to kick off Business of Biotech! #MoffittBOB
Cambridge-based @STORMTherapeutics, a #BioTech company targeting #RNA modifications to reprogram cells and develop novel #cancer therapies, today announced that it has secured €47.5 million in Series C financing. 🇬🇧 🧬💉 eu-startups.com/2026/04/storm-…
Fully Exited $LDX today, broke the channel and the 18.5c support. Set a tight stop which I usually do not do on core positions. The selling continues. Happy to sit it out and look for confirmation on the next couple quarterlies. How fast the tide turned. #biotech #medtech
🇦🇷 Se logró, ciudad de la furia! mi 1ra vez en @alephhackathon (🌎 web3) gracias @crecimientoar Ya tuve experiencia en Hackatones de IA, NASA Space Apps Challenge, Videojuegos, ya tengo un nuevo storytime junto con @greth725 @bitsofgloria en el track #Biotech con #PlagaAlert
Biotech VCs, long accustomed to a reliable drug-development playbook, are now being upended buff.ly/pNpN7Ax #biotech #VC
$IOVA Institutional Analysis: Latest SEC filings confirm aggressive accumulation by major funds like BlackRock and State Street. Institutional ownership hits 63.68%, with a consensus price target of $9.00 (Yahoo/Finviz). Strong market confidence. #IOVA #Biotech #Investing
🚨 Applications are now open for the 2026 Grand Challenge — apply by May 15, 2026 for a chance to win a $100,000 non-dilutive grant. Learn more and apply here: loom.ly/aVY5TxE #biotech #startup #lifesciences #NonDilutive
JUST ANNOUNCED: KidneyX EMPOWER: Living Link Prize 📢 $4M in prizes. 2 tracks. 1 goal: Expand living kidney donation. Get ready to innovate. 🚀 Learn more: kidneyxempowerchallenge.org #KidneyX #BioTech #NephTwitter @ASNKidney
Something went wrong.
Something went wrong.
United States Trends
- 1. #WWERaw N/A
- 2. Sol Ruca N/A
- 3. Brandon Ingram N/A
- 4. #RawAfterMania N/A
- 5. Ethan Page N/A
- 6. Jalen Johnson N/A
- 7. Thune N/A
- 8. Pens N/A
- 9. Tim Cook N/A
- 10. Porter Martone N/A
- 11. Penguins N/A
- 12. Tippett N/A
- 13. #AmericanIdol N/A
- 14. #IgniteTheOrange N/A
- 15. Mike Brown N/A
- 16. Mitchell Robinson N/A
- 17. Zaria N/A
- 18. Malkin N/A
- 19. Letang N/A
- 20. Crosby N/A